Cytokine release syndrome occurred in 70% of patients, with lower incidence in those pre-treated with 2,000 mg Gazyva. Severe ...

This is a news collection page for Canberra. Check this page for latest news headlines covering major stories, events from Canberra and surrounding ACT. Get breaking news faster than any other ...

A range of medications are available to help treat lupus nephritis (LN), each offering a specific role in managing the ...

NEW YORK, Oct. 29, 2024 /PRNewswire/ -- Canopy, the first Continuous Care Platform for oncology, today announced the strategic expansion of its leadership team with the appointments of Josh Neiman ...

Novartis and Apellis Pharmaceuticals have rolled out detailed data on iptacopan and pegcetacoplan, respectively, as they race for the prize in a type of rare kidney disease. Saturday, Apellis laid ...

In these studies, there were 83.1% of patients in the obinutuzumab group and 63.4% in the rituximab group who achieved MRD negativity by bone marrow testing. In the study, researchers used ...

A screenshot of the ABC News-hosted presidential debate between Kamala Harris and Donald Trump in September 2024. Picture: Youtube screenshot of Wall Street Journal debate stream Half of the world ...

Last month, Donald Trump announced that he was selling limited-edition, gaudy watches ranging from $499 to the bargain price of $100,000, bragging about their Swiss-made precision. But a CNN ...

Roche’s recent Phase III REGENCY trial results for Gazyva (obinutuzumab) suggest the therapy could directly address these needs. Gazyva, a CD20-directed cytolytic antibody, met its primary endpoint by ...

Roche announced positive topline results from the phase III REGENCY study of Gazyva/Gazyvaro (obinutuzumab) in people with active lupus nephritis. In the study, a higher proportion of people treated ...